Table 2 Cardiac magnetic measurement parameters
From: NOX4 expression and distal arteriolar remodeling correlate with pulmonary hypertension in COPD
|  | Control (n = 19) | COPD (n = 15) | t/t’ | P |
|---|---|---|---|---|
mPAP (mmHg) | 22.78±1.62 | 24.98±3.68 | −1.40 | 0.02 |
mPADmax (mm) | 26.96±2.13 | 30.36±3.34 | −3.61 | 0.00 |
mPADmin (mm) | 22.06±2.15 | 24.91±2.50 | −3.59 | 0.00 |
CSAmax (cm2) | 5.77±0.99 | 6.98±0.95 | −3.60 | 0.00 |
CSAmin (cm2) | 3.69±0.69 | 4.91±0.98 | −4.26 | 0.00 |
mPAD (%) | 57.29±14.47 | 43.82±10.87 | 2.99 | 0.01 |
PPV (cm/s) | 69.71±15.76 | 74.71±26.79 | −0.68 | 0.50 |
PNV (cm/s) | 21.42±14.28 | 27.31±14.81 | −1.18 | 0.25 |
AF (ml/beat) | 70.01±22.00 | 64.73±17.31 | 0.76 | 0.45 |
APF (ml/beat) | 72.93±22.27 | 68.50±16.75 | 0.64 | 0.53 |
ANF (ml/beat) | 3.25±2.00 | 5.27±2.55 | −2.60 | 0.01 |
RF (%) | 4.68±3.04 | 7.91±3.74 | −2.78 | 0.01 |
RVEDV (ml) | 124.28±21.53 | 122.15±25.78 | 0.26 | 0.80 |
REESV (ml) | 58.51±14.57 | 58.63±22.03 | −0.02 | 0.99 |
RVSV (ml) | 65.77±16.68 | 63.53±13.99 | 0.42 | 0.68 |
RVEF (%) | 52.81±10.19 | 51.27±8.97 | 0.46 | 0.65 |
RVMED (g) | 32.94±4.31 | 40.03±8.55 | −2.93 | 0.00 |
RVMES (g) | 28.05±5.00 | 32.87±8.10 | −2.132 | 0.04 |
RVMI (g/m2) | 0.38±0.08 | 0.46±0.13 | 0.10 | 0.04 |